Although the reasons for the observed histology-specific difference in the risk conferred by the COX-2 polymorphism remain to be elucidated, this difference may be attributable to the differences in the pathways of carcinogenesis among the different histological types of lung cancer. The gene discussed is PTGS2; the disease is lung cancer.